Mitochondrial Peroxiredoxin III is a Potential Target for Cancer Therapy

Author： Song In-Sung   Kim Hyoung-Kyu   Jeong Seung-Hun   Lee Sung-Ryul   Kim Nari   Rhee Byoung Doo   Ko Kyung Soo   Han Jin  

Publisher： MDPI

E-ISSN： 1422-0067|12|10|7163-7185

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.12, Iss.10, 2011-10, pp. : 7163-7185

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Survivin as a Preferential Target for Cancer Therapy

By Mobahat Mahsa   Narendran Aru   Riabowol Karl  

International Journal of Molecular Sciences, Vol. 15, Iss. 2, 2014-02 ,pp. : 2494-2516

MDPI

Access to resources Recommend Favorite

Molecular Approaches To Target GPCRs in Cancer Therapy

By Innamorati Giulio   Valenti Maria Teresa   Giovinazzo Francesco   Carbonare Luca Dalle   Parenti Marco   Bassi Claudio  

Pharmaceuticals, Vol. 4, Iss. 4, 2011-03 ,pp. : 567-589

MDPI

Access to resources Recommend Favorite

Mitochondrial FAD-linked Glycerol-3-phosphate Dehydrogenase: A Target for Cancer Therapeutics

By Singh Gurmit  

Pharmaceuticals, Vol. 7, Iss. 2, 2014-02 ,pp. : 192-206

MDPI

Access to resources Recommend Favorite

The Double Role of p53 in Cancer and Autoimmunity and Its Potential as Therapeutic Target

By Fierabracci Alessandra   Pellegrino Marsha  

International Journal of Molecular Sciences, Vol. 17, Iss. 12, 2016-11 ,pp. : 1975-1975

MDPI

Access to resources Recommend Favorite

Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer

By Su Yin-Jie   Yu Jin   Huang Ya-Qin   Yang Jin  

International Journal of Molecular Sciences, Vol. 16, Iss. 6, 2015-06 ,pp. : 13322-13338

MDPI

Access to resources Recommend Favorite